A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251

Clinical trial NCT02449018 · COMPLETED

Trial details

NCT number: NCT02449018
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease, COPD

Start date: 2015-04-30
Primary completion: 2016-12-27
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.